Application 007517
- Type
- NDA
- Sponsor
- KING PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | TAPAZOLE | METHIMAZOLE | TABLET;ORAL | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 004 | TAPAZOLE | METHIMAZOLE | TABLET;ORAL | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N007517-002 | TAPAZOLE | METHIMAZOLE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | ||
| N007517-004 | TAPAZOLE | METHIMAZOLE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N007517-002 | TAPAZOLE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N007517-004 | TAPAZOLE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N007517-002 | TAPAZOLE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N007517-004 | TAPAZOLE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N007517-002 | TAPAZOLE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N007517-004 | TAPAZOLE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N007517-002 | TAPAZOLE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N007517-004 | TAPAZOLE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N007517-002 | TAPAZOLE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N007517-004 | TAPAZOLE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N007517-002 | TAPAZOLE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N007517-004 | TAPAZOLE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N007517-002 | TAPAZOLE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N007517-004 | TAPAZOLE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N007517-002 | TAPAZOLE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N007517-004 | TAPAZOLE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N007517-002 | TAPAZOLE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N007517-004 | TAPAZOLE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N007517-002 | TAPAZOLE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N007517-004 | TAPAZOLE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N007517-002 | TAPAZOLE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N007517-004 | TAPAZOLE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N007517-002 | TAPAZOLE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N007517-004 | TAPAZOLE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N007517-002 | TAPAZOLE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N007517-004 | TAPAZOLE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N007517-002 | TAPAZOLE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N007517-004 | TAPAZOLE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N007517-002 | TAPAZOLE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N007517-004 | TAPAZOLE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N007517-002 | TAPAZOLE | 5MG | TABLET / ORAL | RLD, Approved before 1982 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N007517-004 | TAPAZOLE | 10MG | TABLET / ORAL | RLD, Approved before 1982 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N007517-002 | TAPAZOLE | 5MG | TABLET / ORAL | RLD, Approved before 1982 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N007517-004 | TAPAZOLE | 10MG | TABLET / ORAL | RLD, Approved before 1982 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N007517-002 | TAPAZOLE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD, Approved before 1982 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N007517-004 | TAPAZOLE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD, Approved before 1982 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N007517-002 | TAPAZOLE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N007517-004 | TAPAZOLE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N007517-002 | TAPAZOLE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD, Approved before 1982 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N007517-004 | TAPAZOLE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD, Approved before 1982 | 782e0a99824c… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methimazole | METHIMAZOLE | REMEDYREPACK INC. | b53f84ac-4263-478c-883d-aca7ab44fef5 | 2026-07-07 | Warnings, Adverse reactions | METHIMAZOLE |
| Methimazole | METHIMAZOLE | REMEDYREPACK INC. | 2c6a9c70-4ed6-4f05-bc3d-e8e7aca57c2b | 2026-07-06 | Warnings, Adverse reactions | METHIMAZOLE |
| Methimazole | METHIMAZOLE | Preferred Pharmaceuticals Inc. | c1e6f1ee-238c-466e-b223-3c3f63dac9ed | 2026-06-23 | Warnings, Adverse reactions | METHIMAZOLE |
| Methimazole | METHIMAZOLE | Preferred Pharmaceuticals Inc. | 244d76f1-98e6-4305-8768-b104f6a4be07 | 2026-06-23 | Warnings, Adverse reactions | METHIMAZOLE |
| Methimazole | METHIMAZOLE | AvKARE | 545381b6-e9e9-de1e-e063-6294a90a9a97 | 2026-06-15 | Warnings, Adverse reactions | METHIMAZOLE |
| Methimazole | METHIMAZOLE | Chartwell RX, LLC | 5b25e346-11b6-44ed-89f9-ab927232ac19 | 2026-03-10 | Warnings, Adverse reactions | METHIMAZOLE |
| Methimazole | METHIMAZOLE | AiPing Pharmaceutical, Inc. | 06bb4bcc-5e47-48b6-a76c-648f846704e8 | 2026-02-07 | Warnings, Adverse reactions | METHIMAZOLE |
| Methimazole | METHIMAZOLE | Preferred Pharmaceuticals Inc. | 253088bf-00f2-489b-984a-682ef9d89e90 | 2026-01-28 | Warnings, Adverse reactions | METHIMAZOLE |
| methimazole | METHIMAZOLE | Coupler LLC | 490f04db-cb51-bde7-e063-6394a90a5546 | 2026-01-23 | Warnings, Adverse reactions | METHIMAZOLE |
| methimazole | METHIMAZOLE | Coupler LLC | 490f168f-c703-5497-e063-6294a90ade87 | 2026-01-23 | Warnings, Adverse reactions | METHIMAZOLE |
| Methimazole | METHIMAZOLE | Bryant Ranch Prepack | afa2cecc-3fef-4372-8d1e-6bbb06d41b23 | 2025-12-03 | Warnings, Adverse reactions | METHIMAZOLE |
| Methimazole | METHIMAZOLE | Bryant Ranch Prepack | 3f65518b-33da-48d8-9af2-2a750400b401 | 2025-12-03 | Warnings, Adverse reactions | METHIMAZOLE |
| Methimazole | METHIMAZOLE | Bryant Ranch Prepack | d05f7950-84cd-413f-9256-4c0977818d25 | 2025-11-06 | Warnings, Adverse reactions | METHIMAZOLE |
| Methimazole | METHIMAZOLE | Bryant Ranch Prepack | 1f6970fb-a549-47b0-b812-48109521d713 | 2025-11-06 | Warnings, Adverse reactions | METHIMAZOLE |
| Methimazole | METHIMAZOLE | AvPAK | 4116774b-6c2b-2c74-e063-6394a90a4955 | 2025-10-13 | Warnings, Adverse reactions | METHIMAZOLE |
| Methimazole | METHIMAZOLE | Macleods Pharmaceuticals Limited | 6f08df05-cc29-45ef-8f6e-12272bfbb0d7 | 2025-09-25 | Warnings, Adverse reactions | METHIMAZOLE |
| methimazole | METHIMAZOLE | Viona Pharmaceuticals Inc. | 05a8fed7-f805-4c59-8840-630174b6d130 | 2025-09-10 | Warnings, Adverse reactions | METHIMAZOLE |
| Methimazole | METHIMAZOLE | Proficient Rx LP | e921f23b-a9bf-4313-9cfa-f0b29c06f72a | 2025-07-01 | Warnings, Adverse reactions | METHIMAZOLE |
| Methimazole | METHIMAZOLE | Preferred Pharmaceuticals Inc. | c063f4c0-d5fe-4b28-b14d-78f73cd7f2c3 | 2025-06-02 | Warnings, Adverse reactions | METHIMAZOLE |
| Methimazole | METHIMAZOLE | Bryant Ranch Prepack | f74a8e69-79a1-4061-b42f-447e0780c04f | 2025-05-13 | Warnings, Adverse reactions | METHIMAZOLE |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 10694 | SUPPL | 2009-03-13 |